STOCK TITAN

BioLife Solutions to Report Second Quarter 2022 Financial Results and Provide Business Update on August 9, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

BioLife Solutions, a supplier of bioproduction tools for cell and gene therapies, will announce its second quarter 2022 financial results after market close on August 9, 2022. A conference call and live webcast are scheduled for 4:30 PM ET, where management will discuss the financial results and provide a business update. The webcast can be accessed via the Investor Relations page on BioLife's website.

Positive
  • None.
Negative
  • None.

BOTHELL, Wash., Aug. 2, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's second quarter 2022 financial results will be released after market close on Tuesday, August 9th. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day.  Management will provide an overview of the Company's financial results and a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free (800) 715-9871 for domestic callers and (646) 307-1963 for international callers. The conference ID number is 2389359. A webcast replay will be available approximately two hours after the call and will be archived on https://www.biolifesolutions.com/ for 90 days.

About BioLife Solutions

BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. Our tools portfolio includes our proprietary CryoStor® and HypoThermosol® biopreservation media for shipping and storage, the ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system,  high capacity cryogenic storage freezersStirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools.  For more information, please visit www.biolifesolutions.com, www.scisafe.com, www.stirlingultracold.com, or www.sextonbio.com and follow BioLife on Twitter.

Contact Information:

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-second-quarter-2022-financial-results-and-provide-business-update-on-august-9-2022-301598254.html

SOURCE BioLife Solutions, Inc.

FAQ

What financial results will BioLife Solutions announce on August 9, 2022?

BioLife Solutions will announce its second quarter 2022 financial results.

When will BioLife Solutions host its conference call for Q2 2022 results?

The conference call will be held on August 9, 2022, at 4:30 PM ET.

How can I access the BioLife Solutions Q2 2022 earnings webcast?

The webcast can be accessed on the Investor Relations page of BioLife Solutions' website.

What is the conference ID for BioLife Solutions earnings call?

The conference ID number is 2389359.

BioLife Solutions Inc.

NASDAQ:BLFS

BLFS Rankings

BLFS Latest News

BLFS Stock Data

1.09B
46.14M
2.02%
102.43%
7.76%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
BOTHELL